Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 226, 114-126
Abstract
No abstract availableKeywords
Funding Information
- Shire
This publication has 44 references indexed in Scilit:
- Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophyInternational Journal of Cardiology, 2013
- Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry DiseasePLOS Genetics, 2013
- Cross‐sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseJournal of Inherited Metabolic Disease, 2012
- Toward a consensus in the laboratory diagnostics of Fabry disease ‐ recommendations of a European expert groupJournal of Inherited Metabolic Disease, 2011
- Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS studyHeart, 2010
- Frequency of Fabry disease in male and female haemodialysis patients in SpainBMC Medical Genetics, 2010
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006
- Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic CardiomyopathyCirculation, 2004
- Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency alleleHuman Mutation, 2003
- Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?Heart, 2003